Your browser doesn't support javascript.
loading
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir.
Cramer, Patrick; Kokic, Goran; Dienemann, Christian; Höbartner, Claudia; Hillen, Hauke S.
Affiliation
  • Cramer P; Abteilung Molekularbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Deutschland.
  • Kokic G; Abteilung Molekularbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Deutschland.
  • Dienemann C; Abteilung Molekularbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Deutschland.
  • Höbartner C; Institut für Organische Chemie, Universität Würzburg, WüRzburg, Deutschland.
  • Hillen HS; Abteilung Molekularbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Deutschland.
Biospektrum (Heidelb) ; 27(1): 49-53, 2021.
Article in De | MEDLINE | ID: mdl-33612990
ABSTRACT
Coronaviruses use an RNA-dependent RNA polymerase to replicate and transcribe their RNA genome. The structure of the SARS-CoV-2 polymerase was determined by cryo-electron microscopy within a short time in spring 2020. The structure explains how the viral enzyme synthesizes RNA and how it replicates the exceptionally large genome in a processive manner. The most recent structure-function studies further reveal the mechanism of polymerase inhibition by remdesivir, an approved drug for the treatment of COVID-19.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: De Journal: Biospektrum (Heidelb) Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: De Journal: Biospektrum (Heidelb) Year: 2021 Document type: Article